Oxford BioMedica (GB:OXB) has released an update.
Oxford BioMedica PLC has announced a significant change in share ownership, with investment giant BlackRock, Inc. crossing the notification threshold on June 27, 2024. BlackRock now holds a combined total of 5.03% of voting rights, with direct voting rights at 3.25% and additional rights through financial instruments. This development could interest shareholders and potential investors as it reflects a notable shift in the company’s ownership structure.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
